CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes

Evandro D. Bezerra; Terra L. Lasho; Christy M. Finke; Antoine N. Saliba; Michelle A. Elliott; Animesh D. Pardanani; Naseema Gangat; Abhishek A. Mangaonkar; Rhett P. Ketterling; Ayalew Tefferi; Eric Solary; Mrinal M. Patnaik

doi:10.1038/s41408-021-00449-9

CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes

Evandro D. Bezerra, Terra L. Lasho, Christy M. Finke, Antoine N. Saliba, Michelle A. Elliott, Animesh D. Pardanani, Naseema Gangat, Abhishek A. Mangaonkar, Rhett P. Ketterling, Ayalew Tefferi, Eric Solary, Mrinal M. Patnaik

Hematology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Article number	54
Journal	Blood cancer journal
Volume	11
Issue number	3
DOIs	https://doi.org/10.1038/s41408-021-00449-9
State	Published - Mar 2021

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1038/s41408-021-00449-9

Cite this

Bezerra, E. D., Lasho, T. L., Finke, C. M., Saliba, A. N., Elliott, M. A., Pardanani, A. D., Gangat, N., Mangaonkar, A. A., Ketterling, R. P., Tefferi, A., Solary, E., & Patnaik, M. M. (2021). CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes. Blood cancer journal, 11(3), Article 54. https://doi.org/10.1038/s41408-021-00449-9

Bezerra, ED, Lasho, TL, Finke, CM, Saliba, AN, Elliott, MA, Pardanani, AD, Gangat, N, Mangaonkar, AA, Ketterling, RP, Tefferi, A, Solary, E & Patnaik, MM 2021, 'CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes', Blood cancer journal, vol. 11, no. 3, 54. https://doi.org/10.1038/s41408-021-00449-9

@article{66a606e0f4ff4277bce26466eb2f34f5,

title = "CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes",

author = "Bezerra, {Evandro D.} and Lasho, {Terra L.} and Finke, {Christy M.} and Saliba, {Antoine N.} and Elliott, {Michelle A.} and Pardanani, {Animesh D.} and Naseema Gangat and Mangaonkar, {Abhishek A.} and Ketterling, {Rhett P.} and Ayalew Tefferi and Eric Solary and Patnaik, {Mrinal M.}",

year = "2021",

month = mar,

doi = "10.1038/s41408-021-00449-9",

language = "English (US)",

volume = "11",

journal = "Blood cancer journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "3",

}

TY - JOUR

T1 - CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes

AU - Bezerra, Evandro D.

AU - Lasho, Terra L.

AU - Finke, Christy M.

AU - Saliba, Antoine N.

AU - Elliott, Michelle A.

AU - Pardanani, Animesh D.

AU - Gangat, Naseema

AU - Mangaonkar, Abhishek A.

AU - Ketterling, Rhett P.

AU - Tefferi, Ayalew

AU - Solary, Eric

AU - Patnaik, Mrinal M.

PY - 2021/3

Y1 - 2021/3

UR - http://www.scopus.com/inward/record.url?scp=85102380172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85102380172&partnerID=8YFLogxK

U2 - 10.1038/s41408-021-00449-9

DO - 10.1038/s41408-021-00449-9

M3 - Letter

C2 - 33707412

AN - SCOPUS:85102380172

SN - 2044-5385

VL - 11

JO - Blood cancer journal

JF - Blood cancer journal

IS - 3

M1 - 54

ER -

CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this